Recombinant plants are desirable production platforms for a variety of valuable biomolecules, including pharmaceuticals and industrial chemicals. However, the maximum yield obtainable from these platforms has been limited by competition with endogenous metabolism and the cytotoxic effects of reactive metabolic intermediates. To solve this problem, my Master’s research focuses on harnessing the process of liquid-liquid phase separation to isolate target pathways from the rest of the metabolism.
